Unexpected Roles of Long Non-Coding RNAs in Cancer Biology

doi:10.1007/s12204-014-1538-y

摘要/Abstract

摘要： Recent studies show that long non-coding RNAs (lncRNAs) play important roles in the regulation of various biological processes, including chromatin remodeling, dosage-compensation, imprinting, and epigenetic regulation. Aberrant expression of lncRNAs is involved in many complex human diseases, including cancer. In this review, we summarized recent progress on lncRNAs detection methodology with emphasis on their functions and potential implication in cancer diagnosis and therapy.

关键词: long non-coding RNA (lncRNAs), epigenetics, transcription, carcinomas

Abstract: Recent studies show that long non-coding RNAs (lncRNAs) play important roles in the regulation of various biological processes, including chromatin remodeling, dosage-compensation, imprinting, and epigenetic regulation. Aberrant expression of lncRNAs is involved in many complex human diseases, including cancer. In this review, we summarized recent progress on lncRNAs detection methodology with emphasis on their functions and potential implication in cancer diagnosis and therapy.

Key words: long non-coding RNA (lncRNAs), epigenetics, transcription, carcinomas

中图分类号:

R730.3

QI Yinga (戚颖), KANG Ya-nia,b (康亚妮), ZHAO Xiao-donga,b* (赵晓东). Unexpected Roles of Long Non-Coding RNAs in Cancer Biology[J]. 上海交通大学学报（英文版）, 2014, 19(5): 544-549.

QI Yinga (戚颖), KANG Ya-nia,b (康亚妮), ZHAO Xiao-donga,b* (赵晓东). Unexpected Roles of Long Non-Coding RNAs in Cancer Biology[J]. Journal of shanghai Jiaotong University (Science), 2014, 19(5): 544-549.

参考文献

[1] Birney E, Stamatoyannopoulos J A, Dutta A, etal. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project [J]. Nature, 2007, 447(7146): 799-816.
[2] van Bakel H, Nislow C, Blencowe B J, et al.Most “dark matter” transcripts are associated with known genes [J]. PLoS Biology, 2010, 8(5): e1000371.1-8.
[3] Clark M B, Mattick J S. Long noncoding RNAs in cell biology [J]. Seminars in Cell & Developmental Biology, 2011, 22(4): 366-376.
[4] Gibb E A, Brown C J, Lam W L. The functional role of long non-coding RNA in human carcinomas [J].Molecular Cancer, 2011, 10(1): 38.1-5.
[5] Okazaki Y, Furuno M, Kasukawa T, et al. Analysis of the mouse transcriptome based on functional annotation of 60 770 full-length cDNAs [J]. Nature, 2002,420(6915): 563-573.
[6] Ng S Y, Johnson R, Stanton L W. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors [J]. EMBO Journal, 2012,31(3): 522-533.
[7] Zhao J, Sun B K, Erwin J A, et al. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome [J]. Science, 2008, 322(5902): 750-756.
[8] Kotake Y, Nakagawa T, Kitagawa K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene [J]. Oncogene, 2011, 30(16): 1956-1962.
[9] Dinger M E, Amaral P P, Mercer T R, et al.Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation [J]. Genome Research,2008, 18(9): 1433-1445.
[10] Gupta R A, Shah N, Wang K C, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis [J]. Nature, 2010,464(7291): 1071-1076.
[11] Atkinson S R, Marguerat S, B¨ahler J. Exploring long non-coding RNAs through sequencing [J]. Seminars in Cell & Developmental Biology, 2012, 23(2):200-205.
[12] H¨uttenhofer A, Schattner P. The principles of guiding by RNA: Chimeric RNA-protein enzymes [J].Nature Reviews Genetics, 2006, 7(6): 475-482.
[13] Tsai M C, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes [J]. Science, 2010, 329(5992): 689-693.
[14] Zhao J, Ohsumi T K, Kung J T, et al. Genomewide identification of polycomb-associated RNAs by RIP-seq [J]. Molecular Cell, 2010, 40(6): 939-953.
[15] Darnell R. CLIP (cross-linking and immunoprecipitation)identification of RNAs bound by a specific protein[J]. Cold Spring Harbor Protocols, 2012, 2012(11):1146-1160.
[16] Hafner M, Landthaler M, Burger L, et al. PARCliP:A method to identify transcriptome-wide the binding sites of RNA binding proteins [J]. Journal of Visualized Experiments, 2010(41): 2034-2037.
[17] Chu C, Qu K, Zhong F L, et al. Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions [J]. Molecular Cell, 2011,44(4): 667-678.
[18] Rinn J L, Kertesz M, Wang J K, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs [J]. Cell, 2007,129(7): 1311-1323.
[19] Pandey R R, Mondal T, Mohammad F, et al.Kcnq1ot1 antisense noncoding RNA mediates lineagespecific transcriptional silencing through chromatinlevel regulation [J]. Molecular Cell, 2008, 32(2): 232-246.
[20] Khalil A M, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression [J]. Proceedings of the National Academy of Sciences USA, 2009, 106(28): 11667-11672.
[21] Margueron R, Reinberg D. The polycomb complex PRC2 and its mark in life [J]. Nature, 2011, 469(7330):343-349.
[22] Luo M, Li Z, WangW, et al. Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression [J].Cancer Letters, 2013, 333(2): 213-221.
[23] Yap K L, Li S, Munoz-Cabello A M, et al. Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a [J]. Molecular Cell,2010, 38(5): 662-674.
[24] Wang K C, Yang Y W, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression [J]. Nature, 2011, 472(7341):120-124.
[25] Prensner J R, Chinnaiyan A M. The emergence of lncRNAs in cancer biology [J]. Cancer Discovery, 2011,1(5): 391-407.
[26] ?rom U A, Shiekhattar R. Noncoding RNAs and enhancers: Complications of a long-distance relationship[J]. Trends in Genetics, 2011, 27(10): 433-439.
[27] Guenther M G, Levine S S, Boyer L A, et al.A chromatin landmark and transcription initiation at most promoters in human cells [J]. Cell, 2007, 130(1):77-88.
[28] Wang X, Arai S, Song X, et al. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription [J]. Nature, 2008, 454(7200): 126-130.
[29] Feng J, Bi C, Clark B S, et al. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator [J]. Genes & Development, 2006, 20(11):1470-1484.
[30] Calin G A, Liu C G, Ferracin M, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas [J]. Cancer Cell, 2007,12(3): 215-229.
[31] Martianov I, Ramadass A, Barros A S, et al. Repression of the human dihydrofolate reductase gene by a non-coding interfering transcript [J]. Nature, 2007,445(7128): 666-670.
[32] Go?ni J R, De La Cruz X, Orozco M. Triplexforming oligonucleotide target sequences in the human genome [J]. Nucleic Acids Research, 2004, 32(1): 354-360.
[33] Mercer T R, Dinger M E, Mattick J S. Long non-coding RNAs: Insights into functions [J]. Nature Reviews Genetics, 2009, 10(3): 155-159.
[34] Katayama S, Tomaru Y, Kasukawa T, et al. Antisense transcription in the mammalian transcriptome[J]. Science, 2005, 309(5740): 1564-1566.
[35] Berx G, Van Roy F. Involvement of members of the cadherin superfamily in cancer [J]. Cold Spring Harbor Perspectives in Biology, 2009, 1(6): a003129.
[36] Beltran M, Puig I, Pena C, et al. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition[J]. Genes & Development, 2008, 22(6): 756-769.
[37] Sch¨oler N, Langer C, D¨ohner H, et al. Serum microRNAs as a novel class of biomarkers: A comprehensive review of the literature [J]. Experimental Hematology,2010, 38(12): 1126-1130.
[38] Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: A new potential biomarker for cancer diagnosis and prognosis [J]. Cancer Science,2010, 101(10): 2087-2092.
[39] Lin R, Maeda S, Liu C, et al. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas [J]. Oncogene, 2007,26(6): 851-858.
[40] Lai M C, Yang Z, Zhou L, et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation[J]. Medical Oncology, 2012, 29(3): 1810-1816.
[41] Yang Z, Zhou L, Wu L M, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation [J]. Annals of Surgical Oncology,2011, 18(5): 1243-1250.
[42] Tinzl M, Marberger M, Horvath S, et al.DD3PCA3 RNA analysis in urine: A new perspective for detecting prostate cancer [J]. European Urology,2004, 46(2): 182-186.
[43] Lee G L, Dobi A, Srivastava S. Prostate cancer:Diagnostic performance of the PCA3 urine test [J]. Nature Reviews Urology, 2011, 8(3): 123-124.
[44] Costa F F. Non-coding RNAs and new opportunities for the private sector [J]. Drug Discovery Today, 2009,14(9-10): 446-452.
[45] Castanotto D, Rossi J J. The promises and pitfalls of RNA-interference-based therapeutics [J]. Nature,2009, 457(7228): 426-433.